Leo told us the further along the trial was, the more valuable the deal would be and he wouldn't take a deal before the Brilacidin phase 3 ABSSSI trial had started. I haven't a clue whether or not Leo will accept a deal at the start or well after the start, or even at the end. All is good either way since an antibiotic trial is much faster than an oncology trial. We should have a partnership sometime this year. I suspect Leo may time the uplisting to coincide with the partnership deal.
In Reply to 'govorchin' me too. i am waiting for B phase 3 . remember BK's post, deal at the start, we gotta b close. before i know it i'll be able to take by original investment out by selling 500 shares. i'll let you know. gov
ps i believe BK has a high probability of being correct. do your own DD